PharmaCyte Biotech, Inc.
http://www.pharmacytebiotech.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From PharmaCyte Biotech, Inc.
Execs On The Move, August 2017
Recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.
Device/Diagnostics Quarterly Deal Statistics, Q1 2016
Device companies raised 50% more in Q1 2016 than the previous quarter, reaching $1.8 billion and led by debt offerings; diagnostic imaging acquisitions, such as Toshiba Medical Systems, were abundant. Diagnostics financings double in Q1, mostly from venture funding, including strong showing from liquid biopsy companies.
Start-Up Previews, April 2016
In this month's issue of Start-Up, we profile Cenna Biosciences, Entac Medical, Hemovent, MediBeacon and Quartet Medicine.
Hemovent GMBH
Hemovent GMBH has developed a miniaturized extracorporeal membrane oxygenation system for bedside use in intensive care. The start-up says the footprint of its ECMO is just 10% the size of the smallest commercially available heart-lung machine, and the cost of the unit is 95% less than a standard ECMO device.
Company Information
- Industry
- Biotechnology
- Pharmaceuticals
-
Pharmaceuticals
- Drug Delivery
- Nutraceuticals
- OTC, Consumer
-
Biotechnology
- Gene Therapy, Cell Therapy
- Large Molecule
- Synthesis Technologies, Production Processes
-
Drug Discovery Tools
- ADMET
- Other Names / Subsidiaries
-
- Bio Blue Bird AG
- eFoodSafety.com
- Medical Marijuana Sciences, Inc.
- Nuvilex Europe Limited
- Nuvilex, Inc.
- Viridis Biotech, Inc.
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice